Non-steroidal anti-inflammatory drugs

00:00 / 00:00

Videos

Notes

Non-steroidal anti-inflammatory drugs

Prerequisite basic sciences

Prerequisite basic sciences

Attributable risk (AR)

Bias in interpreting results of clinical studies

Bias in performing clinical studies

Clinical trials

Confounding

DALY and QALY

Direct standardization

Disease causality

Incidence and prevalence

Indirect standardization

Interaction

Mortality rates and case-fatality

Odds ratio

Positive and negative predictive value

Prevention

Relative and absolute risk

Selection bias

Sensitivity and specificity

Study designs

Test precision and accuracy

Acyanotic congenital heart defects: Pathology review

Adrenal masses: Pathology review

Bacterial and viral skin infections: Pathology review

Bone tumors: Pathology review

Coagulation disorders: Pathology review

Congenital neurological disorders: Pathology review

Cyanotic congenital heart defects: Pathology review

Extrinsic hemolytic normocytic anemia: Pathology review

Eye conditions: Inflammation, infections and trauma: Pathology review

Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review

Headaches: Pathology review

Intrinsic hemolytic normocytic anemia: Pathology review

Leukemias: Pathology review

Lymphomas: Pathology review

Macrocytic anemia: Pathology review

Microcytic anemia: Pathology review

Mixed platelet and coagulation disorders: Pathology review

Nasal, oral and pharyngeal diseases: Pathology review

Nephritic syndromes: Pathology review

Nephrotic syndromes: Pathology review

Non-hemolytic normocytic anemia: Pathology review

Pediatric brain tumors: Pathology review

Pediatric musculoskeletal disorders: Pathology review

Platelet disorders: Pathology review

Renal and urinary tract masses: Pathology review

Seizures: Pathology review

Viral exanthems of childhood: Pathology review

Pharmacodynamics: Agonist, partial agonist and antagonist

Pharmacodynamics: Desensitization and tolerance

Pharmacodynamics: Drug-receptor interactions

Pharmacokinetics: Drug absorption and distribution

Pharmacokinetics: Drug elimination and clearance

Pharmacokinetics: Drug metabolism

Prerequisite basic sciences

Growth hormone and somatostatin

Prerequisite basic sciences

Breastfeeding

Prerequisite basic sciences

Androgens and antiandrogens

Estrogens and antiestrogens

Miscellaneous cell wall synthesis inhibitors

Protein synthesis inhibitors: Tetracyclines

Cell wall synthesis inhibitors: Penicillins

Antihistamines for allergies

Acetaminophen (Paracetamol)

Non-steroidal anti-inflammatory drugs

Antimetabolites: Sulfonamides and trimethoprim

Antituberculosis medications

Cell wall synthesis inhibitors: Cephalosporins

Cell wall synthesis inhibitors: Penicillins

DNA synthesis inhibitors: Fluoroquinolones

DNA synthesis inhibitors: Metronidazole

Miscellaneous cell wall synthesis inhibitors

Miscellaneous protein synthesis inhibitors

Protein synthesis inhibitors: Aminoglycosides

Protein synthesis inhibitors: Tetracyclines

Bronchodilators: Beta 2-agonists and muscarinic antagonists

Bronchodilators: Leukotriene antagonists and methylxanthines

Pulmonary corticosteroids and mast cell inhibitors

Glucocorticoids

Bronchodilators: Beta 2-agonists and muscarinic antagonists

Bronchodilators: Leukotriene antagonists and methylxanthines

Azoles

Glucocorticoids

Pulmonary corticosteroids and mast cell inhibitors

Acetaminophen (Paracetamol)

Non-steroidal anti-inflammatory drugs

Antimetabolites: Sulfonamides and trimethoprim

Cell wall synthesis inhibitors: Cephalosporins

Cell wall synthesis inhibitors: Penicillins

Miscellaneous protein synthesis inhibitors

Protein synthesis inhibitors: Tetracyclines

Pharmacodynamics: Agonist, partial agonist and antagonist

Pharmacodynamics: Desensitization and tolerance

Pharmacodynamics: Drug-receptor interactions

Pharmacokinetics: Drug absorption and distribution

Pharmacokinetics: Drug elimination and clearance

Pharmacokinetics: Drug metabolism

Cell wall synthesis inhibitors: Cephalosporins

Glucocorticoids

Miscellaneous protein synthesis inhibitors

Anticonvulsants and anxiolytics: Barbiturates

Anticonvulsants and anxiolytics: Benzodiazepines

Nonbenzodiazepine anticonvulsants

Cell wall synthesis inhibitors: Cephalosporins

Cell wall synthesis inhibitors: Penicillins

Miscellaneous cell wall synthesis inhibitors

Assessments

Non-steroidal anti-inflammatory drugs

Flashcards

0 / 27 complete

USMLE® Step 1 questions

0 / 7 complete

USMLE® Step 2 questions

0 / 9 complete

Flashcards

Non-steroidal anti-inflammatory drugs

of complete

Questions

USMLE® Step 1 style questions USMLE

of complete

USMLE® Step 2 style questions USMLE

of complete

A 56-year-old man comes to the emergency department for evaluation of acute onset right foot pain. The patient woke up this morning with pain associated with swelling and redness but no fever. The patient does not report any history of recent trauma. Past medical history is significant for hypertension and hyperlipidemia. Current medications include hydrochlorothiazide and atorvastatin. Family history is noncontributory. Temperature is 37.8°C (100°F), pulse is 90/min, respirations are 18/min and blood pressure is 125/75 mmHg. Physical examination shows redness, warmth and a small effusion of the right great toe. A sample of synovial fluid shows needle-shaped negatively birefringent crystals under polarized light microscopy. The physician starts the patient on valdecoxib. This patient is at increased risk of developing which of the following clinical findings?  

External References

First Aid

2022

2021

2020

2019

2018

2017

2016

Anti-inflammatory drugs p. 499

Nonsteroidal anti-inflammatory drugs (NSAIDs) p. 499

Renal disorders/failure p. 626

NSAIDs p. 613

Transcript

Non-steroidal anti-inflammatory drugs or NSAIDs are mainly used to treat inflammation, pain, and fever. These conditions are related to an increased production of pro-inflammatory chemicals called prostaglandins.

NSAIDs work by decreasing the production of prostaglandins, thereby reducing inflammation, relieving pain, and reducing fever.

In order to understand how NSAIDs work, first we need to talk briefly about inflammation, which is the body’s response to a harmful stimulus, such as infection or injury.

So, during inflammation, your immune cells use an enzyme called phospholipase A2 to take membrane phospholipids and make a 20-carbon polyunsaturated fatty acid, called arachidonic acid.

Arachidonic acid is a substrate for an enzyme called cyclooxygenase or COX.

The enzyme cyclooxygenase exists in two different isoforms: COX-1 and COX-2.

COX-1 is a constitutive enzyme, meaning that it’s always active, while on the other hand, COX-2 is an inducible enzyme, meaning that it must be turned on to function. This is usually triggered by immune cells and vascular endothelial cells during inflammation.

Both enzymes produce prostaglandin E2 (PGE2) and prostacyclin (PGI2), which cause vasodilation and attract different immune cells to the area.

They also act on neurons that detect pain, called nociceptors, and make them more sensitive to stimuli by lowering their threshold for activation.

Finally, they stimulate the hypothalamus to increase the body temperature, causing fever.

Prostaglandin E2 also has other effects like causing uterine contractions, decreasing the secretion of acid, and increasing the production of protective mucus in the stomach.

So, in conditions such as inflammation, pain, or fever, NSAIDs can be used to inhibit cyclooxygenase and decrease the production of prostaglandins.

Depending on how they interact with these enzymes, NSAIDs are subdivided into 2 main groups: irreversible COX inhibitors, like aspirin; and reversible COX inhibitors, or non-aspirin NSAIDs.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Aspirin and NSAIDs; benefits and harms for the gut" Best Pract Res Clin Gastroenterol (2012)
  5. "Gastrointestinal safety of selective COX-2 inhibitors" Curr Pharm Des (2002)
  6. "Clinical pharmacology of selective COX-2 inhibitors" Int J Immunopathol Pharmacol (2003)
  7. "The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?" Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (2013)
Elsevier

Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX